"Armored" TRuC Construct Design (TME Shielding) Service

Online Inquiry

Background Service What We Can Offer Workflow Highlights FAQs Contact

Creative Biolabs provides an "Armored" TRuC Construct Design (TME Shielding) Service to address key challenges in solid tumor immunotherapy, including poor T-cell persistence, rapid functional exhaustion, and limited infiltration into immunosuppressive tumor microenvironments. This service enables the development of robust and durable T cell receptor fusion constructs capable of maintaining activity within hostile TMEs. Through advanced immune-engineering strategies, such as cytokine enhanced signaling modules, resistance elements against suppressive factors, and optimized receptor architecture, Creative Biolabs supports the generation of resilient TRuC-T candidates with improved therapeutic durability and anti-tumor performance.

Introduction

The TRuC platform represents a paradigm shift from artificial CAR signaling to physiological TCR engagement. Recent literature confirms that armoring these constructs with membrane-bound cytokines. This "shielding" is critical for overcoming the immunosuppressive microenvironment of solid tumors. In conclusion, armored TRuCs offer superior infiltration, resistance to exhaustion, and a more controlled safety profile for the next generation of adoptive cell therapies.

Service

Creative Biolabs provides a comprehensive suite of solutions to transform standard T cells into resilient, TME-shielded weapons. Our service is grounded in the reality of clinical hurdles: we don't just provide a sequence; we deliver a validated, high-performance biological asset ready for translational development. By utilizing TRuCs instead of conventional CARs, your project benefits from the complete, natural signaling of the TCR complex, which is inherently better suited for the complexities of solid tumor engagement.

Our key capabilities cover custom TRuC construct engineering to design TCR‑fusion constructs optimized for stable expression, efficient antigen recognition, and robust signal transduction in engineered T cells, TME‑shielding module integration to preserve T‑cell function in suppressive microenvironments, functional optimization to enhance signaling and anti‑tumor activity, and flexible design strategies tailored to clients' target antigens, therapeutic goals, and vector systems.

Discover How We Can Help - Request a Consultation.

What We Can Offer

Creative Biolabs offers multiple experimental and engineering platforms to support comprehensive TRuC construct development and evaluation.

Advanced Immune Receptor Engineering Platform	Tumor Microenvironment Simulation Systems
Design and optimization of TRuC constructs with modular domains enabling controlled activation strength and improved receptor stability.	In vitro systems designed to reproduce key suppressive features of solid tumor environments for evaluating engineered T cell performance.
Cytokine-Enhanced Armoring Strategies	Functional Screening and Optimization Platform
Engineering approaches that incorporate immune-supportive signaling modules to strengthen T-cell survival and persistence.	High-content cellular assays to assess activation markers, cytotoxic responses, proliferation capacity, and exhaustion resistance.

Our Workflow

Required Starting Materials: To initiate the design process, clients typically provide the target antigen sequence, specific scFv binder sequences, and preferred T-cell donor requirements.

Workflow of 'Armored' TRuC Construct Design. (Creative Biolabs Original)

Final Deliverables: You will receive a comprehensive Validation Report (including cytotoxicity data and cytokine profiles), the Optimized Genetic Construct, and Preclinical Safety Data.

Core Benefits

Customized Armoring Modules: Selection from a library of membrane-bound cytokines or metabolic enhancers tailored to your specific tumor type.
Physiological Signaling Precision: TRuC architecture that engages all ten ITAMs of the TCR complex, providing potent killing with significantly lower cytokine release compared to CAR-T alternatives.
Exhaustion-Resistant Construct Design: Integration of inhibitory-to-stimulatory "switch" receptors that turn TME suppression signals into activation signals.
Comprehensive TME Simulation: High-throughput in vitro assays that replicate the hypoxic and immunosuppressive conditions of the human tumor microenvironment.

FAQs

Q: What makes TRuCs better than CAR-T for solid tumors?

A: TRuCs engage the entire natural TCR complex, which allows for better tumor penetration and a more physiological activation that avoids the "tonic signaling" and rapid exhaustion common in CAR-T cells.

Q: How do you prevent the T cells from killing each other?

A: We use specific binders that "mask" the target on the T cell itself via a cis interaction, protecting your therapy while it seeks out the tumor.

Q: Will the "armoring" cause systemic toxicity (like a cytokine storm)?

A: Our designs focus on cis-acting cytokines, meaning the IL-15 signals only to the engineered T cell, significantly reducing the risk of bystander NK cell activation and systemic toxicity.

Q: Can I use my own binder sequence with your armored platform?

A: Absolutely. We offer fully customized services and can integrate your proprietary scFv into our optimized TRuC and armoring architectures.

Partner with Us

Creative Biolabs stands at the forefront of TCR-based engineering. Our unique advantage lies in the integration of TRuC technology with bespoke "armoring" that mimics natural immunity while adding a synthetic layer of protection. Unlike generic services, we offer published data support for every construct design, ensuring your therapy is built on a foundation of scientific excellence. For further details, in-depth insights, and a personalised consultation about your project, please feel free to get in touch with our dedicated team. We are ready to answer your questions, explore potential solutions, and support you every step of the way.

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.